Want to see IN:BALAMINES full AI Analyst Report?
BALAMINES Stock Chart & Stats
₹1090.80
₹185.05(10.63%)
At close: 4:00 PM EST
₹1090.80
₹185.05(10.63%)
Day’s Range― - ―
52-Week Range₹905.15 - ₹2,287.00
Previous CloseN/A
Volume2.22M
Average Volume (3M)3.13K
Market Cap
₹67.77B
Enterprise Value₹68.36B
Total Cash (Recent Filing)₹1.86B
Total Debt (Recent Filing)₹314.46M
Price to Earnings (P/E)40.3
Beta0.93
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)45.00
Shares Outstanding32,401,000
10 Day Avg. Volume2,179
30 Day Avg. Volume3,132
Financial Highlights & Ratios
PEG Ratio3.07
Price to Book (P/B)1.60
Price to Sales (P/S)2.22
P/FCF Ratio-18.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)36.9
Revenue Forecast (FY)₹17.37B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery low debt-to-equity (~0.07) and a large equity base provide durable financial flexibility. This reduces refinancing and interest-rate risk, supports capacity expansion or cyclical downturns without stressing credit, and preserves optionality for strategic investments over months.
Diversified B2B End MarketsExposure across pharma, agrochemicals, dyes, rubber chemicals and water treatment provides structural demand diversification. Serving multiple industrial end-markets and both domestic and export channels lowers single-market cyclicality and sustains long-term volume stability.
Healthy Operating MarginsGross margin around 34% and net margin near 11.7% indicate persistent pricing power and higher-value specialty products versus commodities. These margins support reinvestment and buffer raw-material cost swings, underpinning durable profitability despite slower growth.
Bears Say
Negative Free Cash FlowMaterially negative FCF in FY2026 signals heavier reinvestment or working-capital strain and weak cash conversion. Sustained negative FCF can constrain capital returns, force external financing, or delay deleveraging, raising medium-term funding and execution risk.
Modest Revenue GrowthRevenue growth has stabilized but remains modest (~4.4% in FY2026) after prior declines. Limited top-line expansion constrains scale economies and margin recovery, making it harder to materially improve returns or justify large incremental capex without sustained demand gains.
Weakened Capital Efficiency (ROE)ROE moderation to roughly 8–9% indicates the company is generating lower returns on invested capital than in prior peak years. Persistently lower capital efficiency limits shareholder return potential and suggests reinvestments or pricing dynamics are not yielding prior profitability levels.
Balaji Amines Limited News
BALAMINES FAQ
What was Balaji Amines Limited’s price range in the past 12 months?
Balaji Amines Limited lowest stock price was ₹905.15 and its highest was ₹2287.00 in the past 12 months.
What is Balaji Amines Limited’s market cap?
Balaji Amines Limited’s market cap is ₹67.77B.
When is Balaji Amines Limited’s upcoming earnings report date?
Balaji Amines Limited’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were Balaji Amines Limited’s earnings last quarter?
Balaji Amines Limited released its earnings results on May 13, 2026. The company reported ₹20 earnings per share for the quarter, beating the consensus estimate of N/A by ₹20.
Is Balaji Amines Limited overvalued?
According to Wall Street analysts Balaji Amines Limited’s price is currently Overvalued.
Does Balaji Amines Limited pay dividends?
Balaji Amines Limited pays a Annually dividend of ₹10.989 which represents an annual dividend yield of 0.97%. See more information on Balaji Amines Limited dividends here
What is Balaji Amines Limited’s EPS estimate?
Balaji Amines Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Balaji Amines Limited have?
Balaji Amines Limited has 32,401,000 shares outstanding.
What happened to Balaji Amines Limited’s price movement after its last earnings report?
Balaji Amines Limited reported an EPS of ₹20 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.907%.
Which hedge fund is a major shareholder of Balaji Amines Limited?
Currently, no hedge funds are holding shares in IN:BALAMINES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Balaji Amines Limited
Balaji Amines Limited, an Indian company, specializes in the production and global distribution of methylamines, ethylamines, their associated derivatives, alongside a diverse portfolio of specialty chemicals and pharmaceutical excipients. The firm's business activities span three primary divisions: Amines & Speciality Chemicals, its Hotel operations, and CFL Lamp manufacturing. Within its chemical segment, Balaji Amines produces a wide range of amines, including monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl/diethyl amino ethanol. Its specialty chemicals encompass compounds like N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. Additionally, the company provides derivatives such as di-methyl acetamide, various amine hydrochlorides (di-methyl, tri-methyl, di-ethyl, tri-ethyl), di-methyl urea, and choline chloride. For the pharmaceutical industry, it supplies excipients like poly vinyl pyrrolidone. These chemical products cater to a broad array of sectors, including pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning, dye and textile, and water treatment industries. Beyond its chemical endeavors, the company also owns and manages Balaji Sarovar, a hotel property located in Solapur, Maharashtra, and is involved in the manufacturing and sale of CFL lamps. Balaji Amines maintains a significant international presence, exporting its goods to markets across the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and other global regions. The company was founded in 1988 and is headquartered in Hyderabad, India.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Anupam Rasayan India Ltd.
―
Fairchem Organics Ltd
―
Neogen Chemicals Ltd.
―
Rossari Biotech Ltd
―




